Faster Progress,
More Impact

New York City is a growing hub of digital health.

Your company can be part of the generation that impacts lives, creates jobs, and brings New York City to the forefront of global health technology.

Apply now to have your early-stage product piloted in a rapid, small-scale study designed to get you data, fast.

 

The support your early stage company needs

 

The Digital Health Breakthrough Network holds an open competition to select batches of up to four early-stage startups for participation at a time. Watch our website to learn about when the next competition period opens.

Selected New York City-based startups have their technologies stressed and tested in pilot studies with clinical partners and patients around the City. Our studies are designed to be quick and small-scale, so you get the data your early-stage company needs improve your product or pitch to investors. 

 

Companies eligible for selection have: 

 
 
Artboard 2.png

Seed-level funding

>50% of team based in NYC

Not yet generated revenue
from product

 
 

Sound like you? Sign up to get alerted when the next application period opens.


 

HAVE YOUR PRODUCT TESTED IN A REAL-WORLD ENVIRONMENT

Our program serves as a research incubator to give you data to help you scale or pivot your technology as quickly as possible.

Get your technology into the hands of your target end users, now. Selected companies will have their product piloted by HITLAB with input from the Advisory Board. We design a study for your product, secure partner study sites, recruit patients, collect data, and report results directly to you.

 
 

HITLAB Pilot Design

icon-02-clean.jpg

Advisory Board Input

Icon-Placeholder.png

Network Implementation

 
 

Your technology has the potential to be exposed to scores of health practitioners, investors and industry leaders, providing your team with real-market feedback and opportunities.

 

 

Led with Startup Experience

Network leaders NYCEDC and HITLAB have worked with dozens of health startups.

 

ADHERETECH
PSIOUS
NVS TECHNOLOGIES
CEEABLE
RUBITECTION
HOMEWARD HEALTH
NONINVASIX
RISTCALL
SMART VISION LABS
GERIJOY
QOL DEVICES
HINDSAIT, INC.
NONNATECH
CANPOY APPS
URGENT SOFTWARE
ALLAZOHEALTH
HEALTHIFY
TACTONIC TECHNOLOGIES

FIT4D
BIODIGITAL
BIO-SIGNAL GROUP
ECARING
FLATIRON HEALTH
OPTICOLOGY
RIP ROAD
STARLINGHEALTH
SENSE HEALTH
VITAL CARE SERVICES
CONCARLO
REVEAL ANALYTICS
STIRPLATE
THERANOSTICA
PATIENT ENROLLMENT ADVISOR
WELLTH
ADJUVANCE TECHNOLOGIES
ARDENT CELL TECHNOLOGIES
BIND HEALTH
CYNVEC
 

COHEROHEALTH
CUREVAX
HYPERFINE
INVIVO ANALYTICS
NOMOCAN PHARMACEUTICALS
ARL DESIGNS
BROOKLYN BIOSCIENCES
NY PROTEIN BIOLOGICS
OPTOLOGIX
NOMOCAN
SVEIKATAL
ZAKAN THERAPEUTICS
MEDHEXIM1
PHD BIOSCIENCES
AVALIA IMMUNOTHERAPIES
YIVIVA
MYSMILEBUDDY
GENETICAL LENS
ADDICAID
SCALABLE GENOMICS
HYPERFINE
INNOVATIVE NEURONS


 

Industry-Wide Collaboration

NYCEDC and HITLAB regularly collaborate across the entire health spectrum.

 

Join the Network 

Advisors + Members

Get Updates